Top compounds associated with response to STRA13


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.09 0.02
mRNA birinapant CTRPv2 pan-cancer AAC -0.093 0.02
mRNA CP724714 GDSC1000 pan-cancer AAC 0.08 0.02
mRNA JW-480 CTRPv2 pan-cancer AAC -0.091 0.02
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.02
mRNA S-Trityl-L-cysteine FIMM pan-cancer AAC -0.43 0.02
mRNA BAY 61-3606 GDSC1000 pan-cancer AAC -0.08 0.02
mRNA Sorafenib CCLE pan-cancer AAC -0.11 0.02
mRNA NSC-87877 GDSC1000 pan-cancer AAC -0.082 0.03
mRNA tamatinib CTRPv2 pan-cancer AAC -0.088 0.03
Download CSV